Anti-Nasal Spray Market

Introduction of the Anti-Nasal Spray Market Report

Anti-nasal spray is used to relieve symptoms of allergies, colds, rhinitis, with inflammatory agents such as cromolyn sodium, which helps prevent inflammatory substances. They have no side effects and is used by almost every age group. The advancement in the spray’s technology coupled with the increasing number of asthma and allergic patients has surged the nasal sprays’ demand across the globe.

To have an edge over the competition by knowing the market dynamics and current trends of “Anti-Nasal Spray Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The rising burden of severe rhinitis coupled with increasing nasal cavity and nasopharynx infections due to the increasing level of irritants and pollutants has contributed to the market’s growth. Rising burden of asthma across the globe has helped the anti-nasal spray industry shift the paddles and surged the demand for sprays. Furthermore, the increasing number of FDA approvals for nasal sprays has facilitated the growth of the market. For instance, in 2019, FDA announced the approval of Spravato nasal spray to treat patients, which will further contribute to market grwoth. Seasonal allergies coupled with rising risk or recurrent respiratory are the factors that are likely to drive the market’s growth and create an ample opportunity over the forecast period.

Increasing unit capacity or making of nasal sprays by the key players has paced the market’s growth. This increase in capacity reflects the demand and the high potential of the market, which has acted as a driving factor for the market. For instance, Cipla Inc., in 2018 produced 29 million units of sprays and for the fiscal year 2019, more than 29.9 million of unit’s capacity was mapped which reflects the expansion of the production facility and capacity by the company, for meeting the demand for nasal sprays.

Restraint in the Anti-Nasal Spray Market

However, aftereffects of anti-nasal spray like dizziness, high blood pressure is the factor which is likely to hamper the growth of the market.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Patient Type – Segment Analysis

Based on the patient type, the geriatric population segment is expected to dominate the global nasal spray market over the forecast period. This is due to the increasing adult population which is responsible for the growth of the market. For instance, according to a report published by UN, the number of persons over 50 years in anticipated to grow from 2017 to 2050 from 137 to 4235 million, creating scopes of new opportunities for the market over the period.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Europe is anticipated to grow at a higher CAGR in the market over the forecast period. Rising number of allergic cases in Europe, and allergy is the most common disease in the region. For instance, according to “The European Academy of Allergy and Clinical Immunology” (EAACI), more than 150 million Europeans are suffering from chronic allergy diseases. In addition, based on the current cases and predictions, more than 50% of the population will suffer from the chronic allergic disease by the end of 2025, which is anticipated to surge the demand for anti-nasal sprays in European countries like Germany, France, Italy, etc.

Top Market Players

Various notable players operating in the market, include, ADAPT Pharma, Inc., Sandoz International GmbH, INNOVUS PHARMACEUTICALS, INC., Cipla Inc., Aurena, J Pharmaceuticals, Bayer AG, St. Renatus, ARIUS FORMULATIONS PVT LTD, Pfizer Inc., GlaxoSmithKline plc, among others. 

Key Developments:

• • In 2021, Cipla Inc., received FDA approval for generic version of GlaxoSmithKline’s IMITREX, which has helped the company in expanding the product portfolio.

Segments covered in the Report:

The global anti-nasal spray market has been segmented based on type, application, patient type, end-user and regions. Based on type, the market is segmented into saltwater solutions, decongestants, steroid, antihistamine, and others. Based on application, the market is segmented into asthma, cold, nasal allergies, and others. Based on patient type, the market is segmented into infant, paediatric, and adults. 

For detailed scope of the “Anti-Nasal Spray Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global anti-nasal spray market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in anti-nasal spray market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global anti-nasal spray market?
  • Which type generated maximum revenues in 2019 and identify the most promising type during the forecast period?
  • What are the various application areas of global anti-nasal spray market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2019
Market Forecast Period	2020-2027
Market Revenues Currency	USD Million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Type, By Application, By Patient Type, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	ADAPT Pharma, Inc., Sandoz International GmbH, INNOVUS PHARMACEUTICALS, INC., Cipla Inc., Aurena, J Pharmaceuticals, Bayer AG, St. Renatus, ARIUS FORMULATIONS PVT LTD, Pfizer Inc., GlaxoSmithKline plc among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Anti-Nasal Spray Market by Type

• • Saltwater Solutions
  • Decongestants
  • Steroid
  • Antihistamine
  • Others

Global Anti-Nasal Spray Market by Application

• • Asthma
  • Cold
  • Nasal Allergies
  • Others

Global Anti-Nasal Spray Market by Patient Type

• • Infant
  • Paediatric
  • Adults

Global Anti-Nasal Spray Market by Region

• • North America Anti-Nasal Spray Market (Option 1: As a part of the free 25% customization)
    • North America Anti-Nasal Spray Market by Type
    • North America Anti-Nasal Spray Market by Application
    • North America Anti-Nasal Spray Market by Patient Type
    • US Anti-Nasal Spray Market All-Up
    • Canada Anti-Nasal Spray Market All-Up
  • Europe Anti-Nasal Spray Market (Option 2: As a part of the free 25% customization)
    • Europe Anti-Nasal Spray Market by Type
    • Europe Anti-Nasal Spray Market by Application
    • Europe Anti-Nasal Spray Market by Patient Type
    • UK Anti-Nasal Spray Market All-Up
    • Germany Anti-Nasal Spray Market All-Up
    • France Anti-Nasal Spray Market All-Up
    • Spain Anti-Nasal Spray Market All-Up
    • Rest of Europe Anti-Nasal Spray Market All-Up
  • Asia-Pacific Anti-Nasal Spray Market (Option 3: As a part of the free 25% customization)
    • Asia-Pacific Anti-Nasal Spray Market by Type
    • Asia-Pacific Anti-Nasal Spray Market by Application
    • Asia-Pacific Anti-Nasal Spray Market by Patient Type
    • China Anti-Nasal Spray Market All-Up
    • India Anti-Nasal Spray Market All-Up
    • Japan Anti-Nasal Spray Market All-Up
    • Rest of APAC Anti-Nasal Spray Market All-Up
  • RoW Anti-Nasal Spray Market (Option 4: As a part of the free 25% customization)
    • RoW Anti-Nasal Spray Market by Type
    • RoW Anti-Nasal Spray Market by Application
    • RoW Anti-Nasal Spray Market by Patient Type
    • Brazil Anti-Nasal Spray Market All-Up
    • South Africa Anti-Nasal Spray Market All-Up
    • Saudi Arabia Anti-Nasal Spray Market All-Up
    • UAE Anti-Nasal Spray Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Anti-Nasal Spray Market All-Up

Major Players Operating in the Anti-Nasal Spray (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • ADAPT Pharma, Inc.
  • Sandoz International GmbH 
  • INNOVUS PHARMACEUTICALS, INC.
  •  Cipla Inc.
  • Aurena, J Pharmaceuticals
  • Bayer AG
  • Renatus
  • ARIUS FORMULATIONS PVT LTD
  • Pfizer Inc.
  • GlaxoSmithKline plc